Walid M. Awni

First-pass metabolism of cyclosporin by the gut

Joseph C. Kolars, Paul B. Watkins, Robert M. Merion et al. · The Lancet · 1991 · 428 citations · Full text

First-pass Metabolism, Medicine, Physiology +4

The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food Effect

Cheri E. Klein, Yi‐Lin Chiu, Walid M. Awni et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 151 citations

Diminished Food Effect, Pharmaceutical Science, Ritonavir Exposures +13

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir

Rajeev Menon, Prajakta Badri, Tianli Wang et al. · Journal of Hepatology · 2015 · 125 citations · Full text

The Adverse Impact of Cyclosporine on Serum Lipids in Renal Transplant Recipients

Bertram L. Kasiske, Kathryn Tortorice, K L Heim-Duthoy et al. · American Journal of Kidney Diseases · 1991 · 124 citations

Adverse Impact, Kidney Transplant, Kidney Transplantation +7

THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS

Bertram L. Kasiske, K L Heim-Duthoy, K. Venkateswara Rao et al. · Transplantation · 1988 · 112 citations

Transplant Rejection, Urology, Transplantation +13